Alexandra Balbir‐Gurman

A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations

LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab

Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

Favourable outcome of planned pregnancies in systemic sclerosis patients during stable disease

Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study

Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database

Mapping and predicting mortality from systemic sclerosis

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study